How should trichotillomania be managed in a 14-year-old?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Trichotillomania in a 14-Year-Old

Behavioral therapy, specifically habit reversal training (HRT), should be the first-line treatment for this 14-year-old with trichotillomania, with family involvement being essential at this age. 1

Initial Approach: Psychoeducation and Therapeutic Alliance

Begin by establishing a nonjudgmental, empathic relationship with both the adolescent and family. Explain that trichotillomania is a relatively common disorder with effective treatments that can reduce symptoms and improve quality of life 2. Address stigma directly and emphasize that negative feedback or punishment for hair-pulling will not produce positive results 3.

Family involvement is critical in adolescents - parents and family members should be educated about reducing "family accommodation" behaviors (such as providing reassurance, assisting with avoidance, or participating in rituals that enable the hair-pulling) 2.

First-Line Treatment: Behavioral Therapy

Habit reversal training is the most evidence-based psychological treatment and has demonstrated efficacy even in young children, with some data suggesting younger patients may respond as well or better than older adolescents 4, 1. The key components include:

  • Awareness training: Teaching the patient to recognize urges and triggers for hair-pulling
  • Competing response training: Developing alternative behaviors incompatible with hair-pulling
  • Between-session homework: Patient adherence to home exercises is the strongest predictor of both short-term and long-term success 2

Individual or group CBT can be delivered in-person or via internet-based protocols 2. The treatment should integrate cognitive reappraisal (discussing feared consequences and dysfunctional beliefs) with behavioral components to enhance effectiveness 2.

Pharmacological Options: Second-Line or Adjunctive

If behavioral therapy alone is insufficient, unsuccessful, or the patient is unwilling/unable to comply, consider pharmacotherapy:

Preferred Pharmacological Agent

N-acetylcysteine (NAC) is the best first-line pharmacological option due to significant benefits with low risk of side effects 3. This glutamate-modulating agent has demonstrated efficacy in adolescents and adults.

Alternative Pharmacological Options

If NAC is ineffective, consider:

  • Low-dose aripiprazole: A case report demonstrated dramatic improvement in a 14-year-old female with 1.5 mg/day after failed fluvoxamine and CBT monotherapy, without extrapyramidal symptoms 5
  • SSRIs (selective serotonin reuptake inhibitors): Though commonly prescribed in real-world practice 6, evidence is variable. Important caveat: SSRIs carry risk of agitation with suicidal ideation in adolescents 5
  • Other options include tricyclic antidepressants and other glutamate-modulating agents 3

Critical Pitfalls to Avoid

  1. Do not prescribe benzodiazepines as first-line: Despite real-world data showing they are commonly prescribed (37% in US cohorts) 6, this represents poor practice and deviation from evidence-based care
  2. Screen for trichophagia (hair ingestion): This can lead to trichobezoar formation requiring surgical intervention 7. Directly ask about this behavior
  3. Assess for psychiatric comorbidities: High rates of anxiety, depression, and perfectionism exist in TTM patients 8. Address comorbid conditions that may require additional treatment
  4. Avoid punitive approaches: Emphasize to parents that criticism and punishment are counterproductive 3

Treatment Algorithm

  1. Psychoeducation + family involvement (essential foundation)
  2. Habit reversal training/CBT as first-line intervention
  3. If inadequate response after adequate trial: Add N-acetylcysteine
  4. If still inadequate: Consider low-dose aripiprazole or SSRI (with careful monitoring for suicidality)
  5. Psychiatric referral for comprehensive evaluation and management of comorbidities

Interdisciplinary Collaboration

Dermatology-psychiatry liaison is extremely necessary 3. The dermatologist can confirm diagnosis via trichoscopy (showing hair shaft abnormalities from stretching and fracture) and rule out other causes of alopecia, while psychiatry manages the behavioral and pharmacological interventions. This collaborative approach shortens time to diagnosis and appropriate treatment initiation 9.

References

2
Guideline

obsessive-compulsive disorder.

Nature Reviews Disease Primers, 2019

3
Research

Trichotillomania: What Do We Know So Far?

Skin appendage disorders, 2022

Related Questions

Should the patient be referred to psychiatry or psychology for trichotillomania (habitual hair pulling)?
What is trichotillomania and what are the recommended treatment options?
What is the appropriate treatment protocol for a 14-year-old patient with trichotillomania, severe anxiety, and depression?
What is the best first-line pharmacologic treatment for a patient with ADHD and mild trichotillomania?
What are the evidence‑based treatment strategies for trichotillomania?
What is the significance of a free testosterone of 0.4 ng/dL and a total serum testosterone of 7 ng/mL, and how should this be managed?
A patient with chronic auditory hallucinations who refuses clozapine (Clozaril) or haloperidol (Haldol), currently on olanzapine 30 mg at bedtime and risperidone (Risperdal) 2 mg twice daily for 4 days with persistent hallucinations, which first‑generation antipsychotic should be considered?
In a 16-year-old male discontinuing atomoxetine (Strattera) who currently does not meet full DSM‑5 criteria for a major depressive episode or a primary anxiety disorder, and whose ADHD symptoms cannot be fully assessed while on medication, should the existing diagnoses of attention‑deficit hyperactivity disorder, unspecified anxiety disorder, major depressive disorder (single episode), and adolescent‑onset conduct disorder be retained?
How should I manage right jaw and lip numbness in a patient with metastatic breast cancer on Tagrisso (osimertinib) who has right frontal brain lesions with skull bone involvement treated with stereotactic body radiation therapy (SBRT)?
What is the clinical significance and recommended management of a low serum testosterone level (7 ng/dL) measured by liquid chromatography in a female?
Can buspirone (Buspar) be used to treat obsessive‑compulsive disorder, and what is the appropriate dosing regimen?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.